# Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

> **NCT00807768** · PHASE3 · UNKNOWN · sponsor: **Gynecologic Oncology Group** · enrollment: 601 (actual)

## Conditions studied

- Endometrial Clear Cell Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Fatigue
- Neurotoxicity Syndrome
- Obesity
- Stage I Uterine Corpus Cancer AJCC v7
- Stage II Uterine Corpus Cancer AJCC v7

## Interventions

- **RADIATION:** 3-Dimensional Conformal Radiation Therapy
- **DRUG:** Carboplatin
- **RADIATION:** Intensity-Modulated Radiation Therapy
- **RADIATION:** Internal Radiation Therapy
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Paclitaxel
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT00807768
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03-23
- **Primary completion:** 2014-12-29
- **Final completion:** —
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2019-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807768, "Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00807768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*